ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1811

Strong Relationships Between Body Component Changes and Serum Uric Acid Variability

Jiwon Hwang1, Mi Yeon Lee2, Yeonghee Eun3 and Joong Kyong Ahn3, 1Division of Rheumatology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon-si, South Korea, 2Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea

Meeting: ACR Convergence 2023

Keywords: Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1796–1826) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Obesity has a well-known relationship with higher serum uric acid (SUA) levels. Skeletal muscles are another site for producing uric acid as the endogenous pool of purine. However, the actual influence of muscle mass on SUA levels was occasionally investigated.The study aimed to evaluate the impact of changing body components on SUA levels in a large number of Korean healthy populations.

Methods: We investigated 39,505 examinees from health check-up programs between 2015 and 2017. Analysis was separately conducted in men (n = 24,623) and pre- and post-menopausal women (n = 14,810 and n = 702, respectively). Body components including waist-hip ratio (WHR) were assessed using the bioimpedance method. We adopted skeletal muscle mass index (SMI) and fat mass index (FMI) based on body weight (kg). Each study population was categorized into seven groups according to the changes of body components over two years as tertiles of increase and decrease: T3 (the most), T2, and T1 (the least) of increase, no change, and T3 (the most), T2, and T1 (the least) of decrease. Hyperuricemia was defined as SUA ≥ 7mg/dL in men and SUA ≥ 6 mg/dL in women. We analyzed odds ratios (ORs) for achieving the target SUA level (< 6mg/dL) and coefficients for the association with SUA level according to the changes in body components over two years.

Results: The mean age was 38.6 ± 6.5 years in men, 37.2 ± 5.4 years in premenopausal women, and 46.1 ± 8.2 years in postmenopausal women. The mean SUA level was 6.25 ± 1.21 mg/dL in men, 4.23 ± 0.88 mg/dL in premenopausal women, and 4.34 ± 0.91 mg/dL in postmenopausal women. Hyperuricemia was most common in men (26.08%), followed by postmenopausal women (4.42%) and premenopausal women (3.22%). Over two years, the change in muscle mass was mostly within ± 2.5kg and muscle mass decreased more frequently than increased in both men and women. The impact of SMI seemed dose-dependent; the ORs (95% CI) of target attainment for T1, T2, and T3 of SMI increase were 1.10 (1.00-1.20), 1.10 (1.01-1.21), and 1.45 (1.32-1.59) in men and 1.16 (0.82-1.65), 1.48 (1.02-2.15), and 1.48 (1.06-2.06) in premenopausal women whereas the ORs for T1, T2, and T3 of SMI decrease were 1.02 (0.93-1.12), 0.92 (0.84-1.00), and 0.85 (0.77-0.93) in men and 1.18 (0.84-1.65), 0.73 (0.55-0.98), and 0.67 (0.51-0.88) in premenopausal women as compared with the reference group. Of FMI and WHR, the impact seemed inverse. The relationship between the changes in body components and SUA variability was strong and clearly dose-dependent in men and premenopausal women. However, the direction of SUA level changes was not the same among the relationship with body component changes: a positive relationship with FMI and WHR changes while a negative relationship with SMI changes.

Conclusion: We demonstrated that the changes in SMI, FMI, and WHR had a significant impact on achieving the target SUA level and the strong relationship with SUA level variability. Our results could boost the practical advice in clinics regarding physical fitness training for subjects with hyperuricemia and gout.

Supporting image 1

Figure 1. Association between SUA levels and SMI changes. The association was significantly strong and clearly dose-dependent along with the serial adjustment of covariates in the regression model.

Supporting image 2

Figure 2. Association between SUA levels and FMI changes. The association was significantly strong and clearly dose-dependent along with the serial adjustment of covariates in the regression model.

Supporting image 3

Figure 3. Association between SUA levels and WHR changes. The association was significantly strong and clearly dose-dependent along with the serial adjustment of covariates in the regression model.


Disclosures: J. Hwang: None; M. Lee: None; Y. Eun: None; J. Ahn: None.

To cite this abstract in AMA style:

Hwang J, Lee M, Eun Y, Ahn J. Strong Relationships Between Body Component Changes and Serum Uric Acid Variability [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/strong-relationships-between-body-component-changes-and-serum-uric-acid-variability/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/strong-relationships-between-body-component-changes-and-serum-uric-acid-variability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology